Evidence map›Paper›PMID 31046799›Full record

ArticleJournal of experimental & clinical cancer research : CR2019

Glucocorticoid modulatory element-binding protein 1 (GMEB1) interacts with the de-ubiquitinase USP40 to stabilize CFLAR

Wentao An, Shun Yao, Xiaoyang Sun, Zhaoyuan Hou, Yidan Lin, Ling Su, Xiangguo Liu

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Pyrotinib is effective in both trastuzumab-sensitive and primary resistant HER2-positive breast tumors.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Wentao AnShandong Provincial Key Laboratory of Animal Cell and Developmental Biology, School of Life Sciences, Shandong University, Room N8-110, 72 Binhai Road, Qingdao, 266237, People's Republic of China.
Shun YaoShandong Provincial Key Laboratory of Animal Cell and Developmental Biology, School of Life Sciences, Shandong University, Room N8-110, 72 Binhai Road, Qingdao, 266237, People's Republic of China.
Xiaoyang SunShandong Provincial Key Laboratory of Animal Cell and Developmental Biology, School of Life Sciences, Shandong University, Room N8-110, 72 Binhai Road, Qingdao, 266237, People's Republic of China.
Zhaoyuan HouDepartment of Biochemistry and Molecular Cell Biology, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Yidan LinThoracic Surgery Department of West China Hospital, West China Medical School of Sichuan University, Chengdu, China. linyidan@scu.edu.cn.
Ling SuShandong Provincial Key Laboratory of Animal Cell and Developmental Biology, School of Life Sciences, Shandong University, Room N8-110, 72 Binhai Road, Qingdao, 266237, People's Republic of China. suling@sdu.edu.cn.
Xiangguo LiuShandong Provincial Key Laboratory of Animal Cell and Developmental Biology, School of Life Sciences, Shandong University, Room N8-110, 72 Binhai Road, Qingdao, 266237, People's Republic of China. xgliu@sdu.edu.cn.
Shandong Normal University · CNShandong University · CNShanghai Jiao Tong University · CNWest China Medical Center of Sichuan University · CN

Funding

National Natural Science Foundation of China 31571422, 31771526,31371402National Natural Science Foundation of China 81672291National Natural Science Foundation of China 81672855
6 · The paper itself

Abstract

backgroundGMEB1 was originally identified via its interaction with GMEB2, which binds to the promoter region of the tyrosine aminotransferase (TAT) gene and modulates transactivation of the glucocorticoid receptor gene. In the cytosol, GMEB1 interacts with and inhibits CASP8, but the molecular mechanism is currently unknown.

methodsHuman non-small cell lung cancer cells and 293FT cells were used to investigate the function of GMEB1/USP40/CFLAR

resultsWe found GMEB1 interacted with CFLAR

conclusionsOur findings show the de-ubiquitinase USP40 regulates the ubiquitination and degradation of CFLAR

Indexed as

A549 CellsAnimalsApoptosisCarcinoma, Non-Small-Cell LungCASP8 and FADD-Like Apoptosis Regulating ProteinCaspase 8Cell ProliferationGene Expression Regulation, NeoplasticGene Knockdown TechniquesHumansMiceTranscription FactorsUbiquitin ThiolesteraseXenograft Model Antitumor AssaysCASP8 and FADD-Like Apoptosis Regulating ProteinCASP8 protein, humanCaspase 8CFLAR protein, humanGMEB1 protein, humanTranscription FactorsUbiquitin ThiolesteraseUSP40 protein, humanApoptosisCFLARLde-ubiquitinationGMEB1NSCLC cellsUSP40

Identifiers

PMID31046799
PMCPMC6498657
OpenAlexW2947076520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.